PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-04-27

Date Title Company
27-Apr-2020 MDxHealth Announces Growth Investment from MVM Partners MDxHealth SA
27-Apr-2020 Development of rapid, point of care, immunodiagnostic test for detection of the SARS-CoV-2 (COVID-19) Leinco Technologies
27-Apr-2020 Santhera and Cold Spring Harbor Laboratory to Investigate Lonodelestat (POL6014) in COVID-19-related Acute Respiratory Distress Syndrome (ARDS) Santhera Pharmaceuticals
27-Apr-2020 ATAI Life Sciences announces close of $24 million convertible note financing round and welcomes Jason Camm of Thiel Capital to Board of Directors ATAI Life Sciences
27-Apr-2020 NanoPass Is Joining Forces with Pharma Partners in The Fight Against The COVID-19 Pandemic NanoPass
27-Apr-2020 CO.DON AG: Delayed publication of financial statements, agreement on provision of additional liquidity, planned capital increase CO.DON AG
27-Apr-2020 ADC Therapeutics Appoints Victor Sandor, M.D., to Its Board of Directors ADC Therapeutics SA
27-Apr-2020 CTI Biopharma Announces Initiation of Phase 3 PRE-VENT Study Evaluating Pacritinib in Hospitalized Patients with Severe COVID-19 CTI BioPharma Corp.
27-Apr-2020 Abbott Receives Health Canada Authorization under Interim Order to Use FreeStyle® Libre System for Hospitalized Patients During COVID-19 Pandemic Abbott
27-Apr-2020 Global Cord Blood Corporation Provides Further Update on COVID-19 Global Cord Blood Corporation
27-Apr-2020 Global Cord Blood Corporation Provides Further Update on COVID-19 Global Cord Blood Corporation
27-Apr-2020 ARTES Joins Global Combat against Corona B3C newswire
27-Apr-2020 Selvita and Ardigen Will Receive Funding for the Development of an AI-based High-content Screening Platform Selvita
27-Apr-2020 Valo Therapeutics to Support Development of a Pan - Coronavirus Vaccine Valo Therapeutics
27-Apr-2020 Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer Sutro Biopharma
27-Apr-2020 Halozyme Announces Janssen Submits New Drug Application In Japan For Daratumumab Subcutaneous Formulation Utilizing Halozyme's ENHANZE® Technology For Patients With Multiple Myeloma Halozyme Therapeutics, Inc.